This article provides a comprehensive framework for embedding sustainability into the lifecycle of biomimetic biomedical projects.
This article provides a thorough examination of extracellular vesicle (EV) structural stability, addressing critical concerns for researchers and drug development professionals.
Carrier-free nanomedicines (CFNs) offer a paradigm shift in drug delivery by eliminating exogenous carriers, promising higher drug loading, simpler composition, and improved biocompatibility.
This comprehensive review addresses the critical stability and shelf-life challenges facing liposomal formulations in pharmaceutical development.
This article provides researchers, scientists, and drug development professionals with a strategic framework for addressing the complex regulatory landscape of collaborative nanomedicine projects.
This article provides a detailed roadmap for researchers and drug development professionals navigating the complex and evolving regulatory landscape for nanomaterial-enhanced medical devices.
This article provides a comprehensive analysis of quantum dot (QD) blinking, a fundamental photophysical phenomenon that limits their utility in single-molecule tracking (SMT).
This article examines the complex power dynamics inherent in interdisciplinary biomimetic collaborations between biologists, engineers, chemists, and clinicians.
This article critically examines the pervasive naturalistic fallacy in biomimetic design for pharmaceutical research.
This article provides a comprehensive analysis of nanoparticle-induced complement activation (NICA), a critical barrier in nanomedicine development.